tirzepatide decision today FDA's creates uncertainty for patients—and leads to a lawsuit tirzepatide ruling today court on

Tirzepatide: The active ingredient in Mounjaro and Zepbound

Discussion In a population of patients with type 2 diabetes who had no prior diagnosis of eye diseases, this cohort study found that semaglutide or tirzepatide compared with other antidiabetic medications was associated with a differential risk of optic nerve and visual pathways, including increased risk of NAION and other optic nerve disorders, but not optic neuritis, papilledema, optic atrophy, or optic disc orders

In contrast, the placebo group lost about 4% of their body mass

Procedure : The provider injects the substance directly into the targeted fat area